The concept of innovative drugs has rebounded, with CSBIO rising over 15%, reaching a new historical high. Maiwei Biotech increased by over 10%, Anglikon hit the daily limit, and Sinocelltech, Wanbangde, XinNuoWei, and Haichuang Pharmaceutical all surged
